Global Tuberculosis Vaccine Treatment Market Research Report 2025(Status and Outlook)
Description
Report Overview
The tuberculosis (TB) vaccine market primarily revolves around the Bacillus Calmette-Guérin (BCG) vaccine, the only licensed vaccine for TB prevention, which has been in use for nearly a century. While BCG is effective in preventing severe forms of TB in children, its efficacy in adults is inconsistent, particularly against pulmonary TB, the most common and transmissible form. This gap has spurred significant investment in research and development for next-generation TB vaccines, including subunit vaccines, viral vector-based candidates, and mRNA-based approaches. The market is driven by high TB prevalence in low- and middle-income countries, increasing drug-resistant TB strains, and global health initiatives like the WHO's End TB Strategy. However, challenges such as lengthy clinical trials, funding constraints, and regulatory hurdles persist. Emerging candidates like M72/AS01E and VPM1002 show promise in late-stage trials, potentially reshaping the market in the coming years.
The global Tuberculosis Vaccine Treatment market size was estimated at USD 78.6 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 2.93% during the forecast period.
This report provides a deep insight into the global Tuberculosis Vaccine Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tuberculosis Vaccine Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tuberculosis Vaccine Treatment market in any manner.
Global Tuberculosis Vaccine Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market Segmentation (by Type)
Immune Vaccine
Therapy Vaccine
Market Segmentation (by Application)
Self-Procurement
UNICEF
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Tuberculosis Vaccine Treatment Market
Overview of the regional outlook of the Tuberculosis Vaccine Treatment Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis Vaccine Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Tuberculosis Vaccine Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The tuberculosis (TB) vaccine market primarily revolves around the Bacillus Calmette-Guérin (BCG) vaccine, the only licensed vaccine for TB prevention, which has been in use for nearly a century. While BCG is effective in preventing severe forms of TB in children, its efficacy in adults is inconsistent, particularly against pulmonary TB, the most common and transmissible form. This gap has spurred significant investment in research and development for next-generation TB vaccines, including subunit vaccines, viral vector-based candidates, and mRNA-based approaches. The market is driven by high TB prevalence in low- and middle-income countries, increasing drug-resistant TB strains, and global health initiatives like the WHO's End TB Strategy. However, challenges such as lengthy clinical trials, funding constraints, and regulatory hurdles persist. Emerging candidates like M72/AS01E and VPM1002 show promise in late-stage trials, potentially reshaping the market in the coming years.
The global Tuberculosis Vaccine Treatment market size was estimated at USD 78.6 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 2.93% during the forecast period.
This report provides a deep insight into the global Tuberculosis Vaccine Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tuberculosis Vaccine Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tuberculosis Vaccine Treatment market in any manner.
Global Tuberculosis Vaccine Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market Segmentation (by Type)
Immune Vaccine
Therapy Vaccine
Market Segmentation (by Application)
Self-Procurement
UNICEF
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Tuberculosis Vaccine Treatment Market
Overview of the regional outlook of the Tuberculosis Vaccine Treatment Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis Vaccine Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Tuberculosis Vaccine Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
153 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Tuberculosis Vaccine Treatment
- 1.2 Key Market Segments
- 1.2.1 Tuberculosis Vaccine Treatment Segment By Type
- 1.2.2 Tuberculosis Vaccine Treatment Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Tuberculosis Vaccine Treatment Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Tuberculosis Vaccine Treatment Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Tuberculosis Vaccine Treatment Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Tuberculosis Vaccine Treatment Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Tuberculosis Vaccine Treatment Product Life Cycle
- 3.3 Global Tuberculosis Vaccine Treatment Sales By Manufacturers (2020-2025)
- 3.4 Global Tuberculosis Vaccine Treatment Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Tuberculosis Vaccine Treatment Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Tuberculosis Vaccine Treatment Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Tuberculosis Vaccine Treatment Market Competitive Situation And Trends
- 3.8.1 Tuberculosis Vaccine Treatment Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Tuberculosis Vaccine Treatment Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Tuberculosis Vaccine Treatment Industry Chain Analysis
- 4.1 Tuberculosis Vaccine Treatment Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Tuberculosis Vaccine Treatment Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Tuberculosis Vaccine Treatment Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Tuberculosis Vaccine Treatment Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Tuberculosis Vaccine Treatment Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Tuberculosis Vaccine Treatment Sales Market Share By Type (2020-2025)
- 6.3 Global Tuberculosis Vaccine Treatment Market Size Market Share By Type (2020-2025)
- 6.4 Global Tuberculosis Vaccine Treatment Price By Type (2020-2025)
- 7 Tuberculosis Vaccine Treatment Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Tuberculosis Vaccine Treatment Market Sales By Application (2020-2025)
- 7.3 Global Tuberculosis Vaccine Treatment Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Tuberculosis Vaccine Treatment Sales Growth Rate By Application (2020-2025)
- 8 Tuberculosis Vaccine Treatment Market Sales By Region
- 8.1 Global Tuberculosis Vaccine Treatment Sales By Region
- 8.1.1 Global Tuberculosis Vaccine Treatment Sales By Region
- 8.1.2 Global Tuberculosis Vaccine Treatment Sales Market Share By Region
- 8.2 Global Tuberculosis Vaccine Treatment Market Size By Region
- 8.2.1 Global Tuberculosis Vaccine Treatment Market Size By Region
- 8.2.2 Global Tuberculosis Vaccine Treatment Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Tuberculosis Vaccine Treatment Sales By Country
- 8.3.2 North America Tuberculosis Vaccine Treatment Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Tuberculosis Vaccine Treatment Sales By Country
- 8.4.2 Europe Tuberculosis Vaccine Treatment Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Tuberculosis Vaccine Treatment Sales By Region
- 8.5.2 Asia Pacific Tuberculosis Vaccine Treatment Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Tuberculosis Vaccine Treatment Sales By Country
- 8.6.2 South America Tuberculosis Vaccine Treatment Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Tuberculosis Vaccine Treatment Sales By Region
- 8.7.2 Middle East And Africa Tuberculosis Vaccine Treatment Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Tuberculosis Vaccine Treatment Market Production By Region
- 9.1 Global Production Of Tuberculosis Vaccine Treatment By Region(2020-2025)
- 9.2 Global Tuberculosis Vaccine Treatment Revenue Market Share By Region (2020-2025)
- 9.3 Global Tuberculosis Vaccine Treatment Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Tuberculosis Vaccine Treatment Production
- 9.4.1 North America Tuberculosis Vaccine Treatment Production Growth Rate (2020-2025)
- 9.4.2 North America Tuberculosis Vaccine Treatment Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Tuberculosis Vaccine Treatment Production
- 9.5.1 Europe Tuberculosis Vaccine Treatment Production Growth Rate (2020-2025)
- 9.5.2 Europe Tuberculosis Vaccine Treatment Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Tuberculosis Vaccine Treatment Production (2020-2025)
- 9.6.1 Japan Tuberculosis Vaccine Treatment Production Growth Rate (2020-2025)
- 9.6.2 Japan Tuberculosis Vaccine Treatment Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Tuberculosis Vaccine Treatment Production (2020-2025)
- 9.7.1 China Tuberculosis Vaccine Treatment Production Growth Rate (2020-2025)
- 9.7.2 China Tuberculosis Vaccine Treatment Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Merck
- 10.1.1 Merck Basic Information
- 10.1.2 Merck Tuberculosis Vaccine Treatment Product Overview
- 10.1.3 Merck Tuberculosis Vaccine Treatment Product Market Performance
- 10.1.4 Merck Business Overview
- 10.1.5 Merck Swot Analysis
- 10.1.6 Merck Recent Developments
- 10.2 Japan Bcg Lab
- 10.2.1 Japan Bcg Lab Basic Information
- 10.2.2 Japan Bcg Lab Tuberculosis Vaccine Treatment Product Overview
- 10.2.3 Japan Bcg Lab Tuberculosis Vaccine Treatment Product Market Performance
- 10.2.4 Japan Bcg Lab Business Overview
- 10.2.5 Japan Bcg Lab Swot Analysis
- 10.2.6 Japan Bcg Lab Recent Developments
- 10.3 Serum Institute Of India
- 10.3.1 Serum Institute Of India Basic Information
- 10.3.2 Serum Institute Of India Tuberculosis Vaccine Treatment Product Overview
- 10.3.3 Serum Institute Of India Tuberculosis Vaccine Treatment Product Market Performance
- 10.3.4 Serum Institute Of India Business Overview
- 10.3.5 Serum Institute Of India Swot Analysis
- 10.3.6 Serum Institute Of India Recent Developments
- 10.4 Aj Vaccines
- 10.4.1 Aj Vaccines Basic Information
- 10.4.2 Aj Vaccines Tuberculosis Vaccine Treatment Product Overview
- 10.4.3 Aj Vaccines Tuberculosis Vaccine Treatment Product Market Performance
- 10.4.4 Aj Vaccines Business Overview
- 10.4.5 Aj Vaccines Recent Developments
- 10.5 Biofarma
- 10.5.1 Biofarma Basic Information
- 10.5.2 Biofarma Tuberculosis Vaccine Treatment Product Overview
- 10.5.3 Biofarma Tuberculosis Vaccine Treatment Product Market Performance
- 10.5.4 Biofarma Business Overview
- 10.5.5 Biofarma Recent Developments
- 10.6 Greensignal Bio Pharma
- 10.6.1 Greensignal Bio Pharma Basic Information
- 10.6.2 Greensignal Bio Pharma Tuberculosis Vaccine Treatment Product Overview
- 10.6.3 Greensignal Bio Pharma Tuberculosis Vaccine Treatment Product Market Performance
- 10.6.4 Greensignal Bio Pharma Business Overview
- 10.6.5 Greensignal Bio Pharma Recent Developments
- 10.7 China National Biotec
- 10.7.1 China National Biotec Basic Information
- 10.7.2 China National Biotec Tuberculosis Vaccine Treatment Product Overview
- 10.7.3 China National Biotec Tuberculosis Vaccine Treatment Product Market Performance
- 10.7.4 China National Biotec Business Overview
- 10.7.5 China National Biotec Recent Developments
- 10.8 Biomed Lublin
- 10.8.1 Biomed Lublin Basic Information
- 10.8.2 Biomed Lublin Tuberculosis Vaccine Treatment Product Overview
- 10.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Product Market Performance
- 10.8.4 Biomed Lublin Business Overview
- 10.8.5 Biomed Lublin Recent Developments
- 10.9 Taj Pharmaceuticals
- 10.9.1 Taj Pharmaceuticals Basic Information
- 10.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Overview
- 10.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Market Performance
- 10.9.4 Taj Pharmaceuticals Business Overview
- 10.9.5 Taj Pharmaceuticals Recent Developments
- 10.10 Ataulpho De Paiva
- 10.10.1 Ataulpho De Paiva Basic Information
- 10.10.2 Ataulpho De Paiva Tuberculosis Vaccine Treatment Product Overview
- 10.10.3 Ataulpho De Paiva Tuberculosis Vaccine Treatment Product Market Performance
- 10.10.4 Ataulpho De Paiva Business Overview
- 10.10.5 Ataulpho De Paiva Recent Developments
- 10.11 Ivac
- 10.11.1 Ivac Basic Information
- 10.11.2 Ivac Tuberculosis Vaccine Treatment Product Overview
- 10.11.3 Ivac Tuberculosis Vaccine Treatment Product Market Performance
- 10.11.4 Ivac Business Overview
- 10.11.5 Ivac Recent Developments
- 10.12 Queen Saovabha Mem. Inst
- 10.12.1 Queen Saovabha Mem. Inst Basic Information
- 10.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Overview
- 10.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Market Performance
- 10.12.4 Queen Saovabha Mem. Inst Business Overview
- 10.12.5 Queen Saovabha Mem. Inst Recent Developments
- 10.13 Microgen
- 10.13.1 Microgen Basic Information
- 10.13.2 Microgen Tuberculosis Vaccine Treatment Product Overview
- 10.13.3 Microgen Tuberculosis Vaccine Treatment Product Market Performance
- 10.13.4 Microgen Business Overview
- 10.13.5 Microgen Recent Developments
- 11 Tuberculosis Vaccine Treatment Market Forecast By Region
- 11.1 Global Tuberculosis Vaccine Treatment Market Size Forecast
- 11.2 Global Tuberculosis Vaccine Treatment Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Tuberculosis Vaccine Treatment Market Size Forecast By Country
- 11.2.3 Asia Pacific Tuberculosis Vaccine Treatment Market Size Forecast By Region
- 11.2.4 South America Tuberculosis Vaccine Treatment Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Tuberculosis Vaccine Treatment By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Tuberculosis Vaccine Treatment Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Tuberculosis Vaccine Treatment By Type (2026-2033)
- 12.1.2 Global Tuberculosis Vaccine Treatment Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Tuberculosis Vaccine Treatment By Type (2026-2033)
- 12.2 Global Tuberculosis Vaccine Treatment Market Forecast By Application (2026-2033)
- 12.2.1 Global Tuberculosis Vaccine Treatment Sales (K Mt) Forecast By Application
- 12.2.2 Global Tuberculosis Vaccine Treatment Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
